Taylor Stacy L 4
4 · Adaptive Biotechnologies Corp · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Award
Stock Option (right to buy)
2024-03-04+60,010→ 60,010 totalExercise: $3.99Exp: 2034-03-04→ Common Stock (60,010 underlying) - Award
Common Stock
2024-03-04+39,990→ 179,668 total - Sale
Common Stock
2024-03-05$3.44/sh−6,609$22,735→ 166,287 total - Sale
Common Stock
2024-03-05$3.43/sh−6,772$23,228→ 172,896 total
Footnotes (2)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The options vest with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.